Forum LABO Paris 2027

Inside the Joint Laboratory Service - SCL

Mar 23, 2027 — 02:00 pm - 3:00 PM
Salle Marie Curie

Biotechnology, science and healthcare of tomorrow
Inside the Joint Laboratory Service - SCL

Description

The Joint Laboratory Service stands out for its unique way of operating, making it a network of official laboratories at the heart of government action. It works for several government bodies on an extremely wide range of issues, from toys to narcotics, from verifying the accuracy of claims to food safety, as well as checking geographical origins and the naturalness of ingredients. Its scope of expertise covers 29 scientific fields and includes handling samples collected by inspection authorities, both for high-volume routine analyses (for example, pesticide residues in imported fruit and vegetables) and for in-depth expert investigations on specific topics (for example, the structural elucidation of new psychoactive substances using NMR and high-resolution mass spectrometry).

In partnership with

Suggested sessions

Salle Marie Curie
Mar 23, 2027
3:00 PM3:45 PM
Biotechnology, science and healthcare of tomorrow

Hemarina – a human, scientific and entrepreneurial adventure

Description
Oxygen is essential to life, and hemoglobin is the molecule responsible for transporting almost all of the oxygen present in the circulatory system of most living species. During this conference, our speaker will retrace the story of the discovery of a natural extracellular hemoglobin called M101, derived from a marine organism, Arenicola marina, and its applications in medicine. This non-allergenic and non-immunogenic molecule carries 40 times more oxygen than HbA and is 250 times smaller than a red blood cell. Its intrinsic properties make it a broad-spectrum therapeutic tool for ensuring effective tissue oxygenation in various clinical situations where ischemia and/or anemia are the triggering factors. The applications of the M101 molecule are almost limitless, as it can potentially act wherever oxygen is needed: in composite tissue transplants (organs, skin, face, limbs, etc.), during vaso-occlusive crises in patients with sickle cell disease, in cases of myocardial infarction, cerebral ischemia, in oncology (radiotherapy, CAR-T cells for hypoxic tumors), in the development of oxygenating dressings for hypoxic wounds, and in the treatment of periodontal diseases. This presentation will provide an overview of the development of the M101 molecule and its various therapeutic applications.
HEMARINA
Agora
Mar 23, 2027
3:00 PM3:45 PM
Biotechnology, science and healthcare of tomorrow

SFSTP +POLEPHARMA

Agora
Mar 24, 2027
12:00 PM12:45 PM
Biotechnology, science and healthcare of tomorrow

New approaches to biopharmaceutical analysis - AFSEP

Speakers:
Prof. Davy GUILLARMEUniversité de Lyon / Université de GenèveDocteur en chimie analytique et Professeur associé
Description
Biopharmaceutical drugs are playing an increasingly important role in the pharmaceutical industry. This evolution is accompanied by a wide diversity of molecules, including monoclonal antibodies and their derivatives, oligonucleotides, messenger RNA, as well as cell and gene therapies. Their size, structure, and complexity make their analysis particularly challenging. Yet in-depth characterization is essential to verify their identity, purity, and integrity, detect variants and impurities, and better understand the links between their properties and their biological activity. This presentation will first cover the main families of biopharmaceuticals and the analytical challenges they raise. It will then show how different chromatographic approaches, with or without mass spectrometry, can contribute to their characterization. Examples will illustrate the complementarity of chromatographic modes, the development of rapid analyses, coupling with MS, and method automation. Finally, the biopharmaceuticals of tomorrow are expected to become even more complex, particularly with the rise of conjugated molecules combining several types of compounds. This evolution will require the continued development of adapted analytical strategies capable of providing ever more comprehensive and reliable information.
AFSEP
Agora
Mar 24, 2027
3:00 PM3:45 PM
Biotechnology, science and healthcare of tomorrow

SFM

Description
Microbiology, antimicrobial resistance and the One Health approach
Salle Marie Curie
Mar 25, 2027
10:00 AM10:45 AM
Biotechnology, science and healthcare of tomorrow

FRANCE BIOLEAD

Salle Marie Curie
Mar 25, 2027
11:00 AM11:45 AM
Biotechnology, science and healthcare of tomorrow

POLEPHARMA